Amy Kruse

Amy Kruse is a neuroscientist, technology leader, and General Partner and Chief Investment Officer of Satori Neuro, a venture investment strategy within Satori Capital focused on mental health, neurotechnology, and human flourishing. Previously, she was a General Partner at Prime Movers Lab, Chief Scientific Officer at Optios, and Vice President and Chief Technology Officer at Cubic Global Defense.

She earned her B.S. in Cell and Structural Biology and Ph.D. in Neuroscience from the University of Illinois Urbana-Champaign, where she received a National Science Foundation Graduate Fellowship.

Earlier in her career, she served as a program manager at DARPA, pioneering neuroscience initiatives in augmented cognition, accelerated learning, and neuromodulation. Today, she supports emerging companies developing brain–computer interfaces, neurotherapeutics, and innovative technologies for brain health. She also advises scientific organizations and serves on several neurotechnology company boards.